Raised serum transaminase levels injuvenile rheumatoid arthritis (JRA) treated with salicylates have been reported by Russell, Sturge, and Smith (1971 Case report A 15-year-old boy was referred to the Leiden University Medical Centre. During hospitalization elsewhere he had been treated for suspected rheumatic fever with salicylates in doses up to 6 g. daily for 2 weeks, and 3 days before his admission at Leiden, the excision of a lymph node from the right axilla (histology: non-specific inflammation) had resulted in profuse bleeding requiring five blood transfusions (2,500 ml.). Thrombocytopenia had been demonstrated (thrombocytes 20,000 per p1. 
Raised serum transaminase levels injuvenile rheumatoid arthritis (JRA) treated with salicylates have been reported by Russell, Sturge, and Smith (1971) . The present communication describes a second complication apparently coinciding with this sign of liver injury during administration of salicylates.
Methods
Serum transaminases were determined according to the method ofKarmen, Wrobleski, and La Due (1955) (normal values for our laboratory: SGOT and SGPT up to 15 i.u./ litre), serum salicylate levels with Trinder's reagent, fibrinogen according to the method of Clauss (1957) , fibrinogen degradation products (FDP) by the immunodiffusion technique (Ouchterlony), and Factor V according to the method of Borchgrevink, Pool, and Stormorken (1960) .
Case report A 15-year-old boy was referred to the Leiden University Medical Centre. During hospitalization elsewhere he had been treated for suspected rheumatic fever with salicylates in doses up to 6 g. daily for 2 weeks, and 3 days before his admission at Leiden, the excision of a lymph node from the right axilla (histology: non-specific inflammation) had resulted in profuse bleeding requiring five blood transfusions (2,500 ml.). Thrombocytopenia had been demonstrated (thrombocytes 20,000 per p1. Because of the diagnosis of JRA, salicylates were administered in a dosage of 4 g./day. On this regime the classical signs of salicylism appeared: the liver function again deteriorated, the serum transaminase levels rose, and consumption coagulopathy developed (Figure) .
Upon discontinuation of salicylates after 4 days of treatment, the transaminase levels returned to normal within a week and the coagulopathy disappeared. Thereafter salicylates were given for the third time, but in a gradually increasing dosage starting with 2 g./day. At a point between 3 and 4 g. /day, elevation of transaminase (Janota, Wincey, Sandiford, and Smith, 1960) , children with rheumatic fever (Manso, Taranta, and Nydick, 1965) , and recently in children with JRA (Russell and others, 1971) . The latter ruled out the possibility that salicylates interfere with the serum transaminase assay at the salicylate levels under discussion.
The rise in serum transaminase levels in our patient, among others, was accompanied by a deterioration ofliver function. This, and the fact that the histological picture of the liver in salicylate-treated animals is characterized by cloudy swelling and fatty infiltration (Janota and others, 1960) , makes liver injury the most likely explanation for the increased serum transaminases. A liver biopsy was not performed on our patient because of the haemorrhagic diathesis caused by the consumption coagulopathy.
Study of the literature has failed to yield any report of a relationship between consumption coagulopathy and salicylate dosages, as suggested here. However, Kornreich, Malouf, and Hanson (1971) described seven children with acute changes in hepatic function during the course of JRA. Five of these patients, who were treated with salicylates, showed an abrupt drop in the Erythrocyte Sedimentation rate concomitant with the appearance of hepatic dysfunction as well as raised serum transaminase levels. The fact that these patients also had consumptive coagulopathy is highly suggestive.
At this stage it would, however, be premature to discuss a possible causal relationship between liver injury and consumption coagulopathy, although other coincidences have been observed, particularly in cases of acute fatty metamorphosis of the liver occurring in the last weeks of pregnancy (Sheehan, 1961; Gevers, Loeliger, Veltkamp, Kreuning, and de Jong, 1969) , acute hepatic necrosis (Rake, Flute, Pannell and Williams, 1970) , and liver cirrhosis (Johansson, 1964) .
It is well known that salicylates induce thrombocytopathy. Our case demonstrates that consumption coagulopathy may occur as well. This stresses the need for extreme precaution when biopsies or other surgical procedures are considered for patients being treated with salicylates.
Summary
Consumption coagulopathy related to salicylate therapy is described in a patient suffering from juvenile rheumatoid arthritis. This hitherto unreported complication coincided with signs of liver injury described by other workers. 
